4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000134
EVP, Chief Scientific Officer sold 85,089 shares at an average $79.23 ($6,741,669)
- EVP, Chief Scientific Officer acquired 65,089 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BENNETT C FRANK · EVP, Chief Scientific Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +16,463 | $32.60 | $536,694 | 117,017 | D |
| 2026-03-03 | Exercise or conversion : show line 2 in the form 10b5-1 | +48,626 | $60.89 | $2,960,837 | 165,643 | D |
| 2026-03-03 | Sale : show line 3 in the form 10b5-1 | −71,600 | $79.10 | $5,663,488 | 94,043 | D |
| 2026-03-03 | Sale : show line 4 in the form 10b5-1 | −12,687 | $79.88 | $1,013,410 | 81,356 | D |
| 2026-03-03 | Sale : show line 5 in the form 10b5-1 | −802 | $80.76 | $64,771 | 80,554 | D |
| Open-market sales · 85,089 sh · avg $79.23 · $6,741,669 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-03 | Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −16,463 | 2,406 | D |
| 2026-03-03 | Exercise or conversion : show line 7 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −48,626 | 0 | D |
Loading xslF345X05/edgardoc.xml…